futuristic-global13g.htm -- Converted by SEC Publisher, created by BCL Technologies Inc., for SEC Filing
Washington, D.C. 20549 


Under the Securities Exchange Act of 1934

(Amendment No. 1  )* 

Global Med Technologies, Inc.
(Name of Issuer)

Common Stock
(Title of Class of Securities)

(CUSIP Number)

October 27, 2007
(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

¨   Rule 13d-1(b)
x    Rule 13d-1(c)
¨ Rule 13d-1(d)

*The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with
respect to the subject class of securities, and for any subsequent amendment containing information which
would alter the disclosures provided in a prior cover page.

The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose
of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that
section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.

Page 1 of 5 pages

CUSIP No. 37935E101

  1.    Names of Reporting Persons.

         I.R.S. Identification Nos. of above persons (entities only).
         Futuristic Image Builder Ltd.

2.      Check the Appropriate Box if a Member of a Group (See Instructions)
3.      SEC Use Only
4.      Citizenship or Place of Organization
Number of    5. Sole Voting Power 
Shares Bene-       2,956,081 
ficially by    6. Shared Voting Power 
Owned by Each         
Reporting    7. Sole Dispositive Power  
Person With:       2,956,081   
    8. Shared Dispositive Power 

 9.  Aggregate Amount Beneficially Owned by Each Reporting Person


10.  Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)

11. Percent of Class Represented by Amount in Row (9) 
12. Type of Reporting Person (See Instructions)

Page 2 of 5 pages


CUSIP No. 37935E101

Item 1.

(a)      Name of Issuer
  Global Med Technologies, Inc.
(b)      Address of Issuer’s Principal Executive Offices
12600 West Colfax, Suite C-420, Lakewood, CO 80215

Item 2.

(a)      Name of Person Filing
Futuristic Image Builder Ltd.
(b)      Address of Principal Business Office or, if none, Residence
300 Beach Road, #28-02 The Concourse Singapore 199555
(c)      Citizenship
  Incorporated in Singapore
(d)      Title of Class of Securities
Common Stock
(e)      CUSIP Number

Item 3.

If this statement is filed pursuant to §§240.13d -1(b) or 240.13d -2(b) or (c), check whether the person filing is a:


Item 4. Ownership.

Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1.

(a)      Amount beneficially owned: 2,956,081.
(b)      Percent of class: 11.3%.
(c)      Number of shares as to which the person has:
  (i)      Sole power to vote or to direct the vote : 2,956,081
  (ii)      Shared power to vote or to direct the vote .
  (iii)      Sole power to dispose or to direct the disposition of :2,956,081
  (iv)      Shared power to dispose or to direct the disposition of .

Item 5. Ownership of Five Percent or Less of a Class


Item 6. Ownership of More than Five Percent on Behalf of Another Person.


Page 3 of 5 pages

CUSIP No. 37935E101

Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company


Item 8. Identification and Classification of Members of the Group


Item 9. Notice of Dissolution of Group


Item 10. Certification

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for
the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held
in connection with or as a participant in any transaction having that purpose or effect.








Page 4 of 5 pages

CUSIP No. 37935E101


     After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

November 20, 2007

/s/ Tong Wan Chan                                                         

Tong Wan Chan/ Director







Page 5 of 5 pages